Akshay Gupte
Profiles

Akshay Nitin Gupte, PhD

Assistant Professor, Global Health - Boston University School of Public Health

Biography

Dr. Gupte is a physician-scientist whose research is focused on the intersection of infectious and chronic lung diseases in low- and middle-income settings. He leads several Indo-US collaborative studies to describe the epidemiology and pathogenesis of lung injury in tuberculosis (TB)/HIV/diabetes, measure its impact on poor clinical outcomes, and identify therapeutic and programmatic interventions to improve post-TB lung health and longevity.

Dr. Gupte serves on several multi-national TB/HIV research consortia, such as the TB Transformative Science Working Group of the AIDS Clinical Trials Group (ACTG), Lung Health Working Group of the International Epidemiology Databases to Evaluate AIDS (IeDEA) network, and is Chairperson of the Clinical and Epidemiology Working Group of the RePORT-India TB Research Consortium.

Dr. Gupte completed his medical training in India, Master’s and Doctoral training from the Johns Hopkins Bloomberg School of Public Health, and has previously served as faculty in the Division of Infectious Diseases, Johns Hopkins School of Medicine. He is a 2017 Fogarty Fellow and recipient of the Arthur M. Dannenberg, Jr., Award for excellence in TB research.

Education

  • Maharashtra University of Health Science, MD Field of Study: Medicine-Internal
  • Johns Hopkins University School of Public Health, PhD Field of Study: Global Health
  • Johns Hopkins University School of Public Health, MSPH Field of Study: Epidemiology/International Health
  • Maharashtra University of Health Science, BA Field of Study: Medicine

Publications

  • Published on 3/11/2024

    Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hofmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE. Correction: Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts. Trials. 2024 Mar 11; 25(1):178. PMID: 38468342.

    Read At: PubMed
  • Published on 12/1/2023

    Paradkar MS, Pradhan NN, Balaji S, Gaikwad SN, Chavan A, Dharmashale SN, Sahasrabudhe T, Lokhande R, Deshmukh SA, Barthwal M, Atre S, Raskar SS, Sawant TU, Gupte AN, Kakrani A, Golub J, Padmapriyadarsini C, Gupta A, Gupte NA, Mave V. Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes. Ann Am Thorac Soc. 2023 Dec; 20(12):1760-1768. PMID: 38038600.

    Read At: PubMed
  • Published on 9/4/2023

    Pardeshi G, Mave V, Gaikwad S, Kadam D, Barthwal M, Gupte N, Atre S, Deshmukh S, Golub JE, Gupte A. Glycated Hemoglobin Trajectories and Their Association With Treatment Outcomes Among Patients With Pulmonary TB in India: A Prospective Cohort Study. Chest. 2024 Feb; 165(2):278-287. PMID: 37673207.

    Read At: PubMed
  • Published on 5/12/2023

    Queiroz ATL, Vinhaes CL, Fukutani ER, Gupte AN, Kumar NP, Fukutani KF, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Paradhkar M, Viswanathan V, Gupta A, Andrade BB, Kornfeld H. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep. 2023 May 12; 13(1):7769. PMID: 37173394.

    Read At: PubMed
  • Published on 4/17/2023

    Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis. 2023 Apr 17; 76(8):1483-1491. PMID: 36424864.

    Read At: PubMed
  • Published on 1/1/2023

    Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar SVBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Golub JE. Characterising cause of death among people treated for drug-susceptible TB in India. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):78-80. PMID: 36853129.

    Read At: PubMed
  • Published on 11/1/2022

    Romanowski K, Oravec A, Billingsley M, Shearer K, Gupte A, Huaman MA, Fox GJ, Golub JE, Johnston JC. A scoping review of interventions to mitigate common non-communicable diseases among people with TB. Int J Tuberc Lung Dis. 2022 Nov 01; 26(11):1016-1022. PMID: 36281048.

    Read At: PubMed
  • Published on 9/26/2022

    Deshmukh S, Sane M, Gaikwad S, Sahasrabudhe T, Barthwal M, Lokhande R, Raskar S, Kagal A, Dharmshale S, Pradhan N, Gupte A, Alfarisi O, Gupta A, Dooley KE, Gupte N, Golub JE, Mave V. Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in India. Chest. 2023 Apr; 163(4):778-789. PMID: 36174745.

    Read At: PubMed
  • Published on 8/5/2022

    Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hoffmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts. Trials. 2022 Aug 05; 23(1):635. PMID: 35932062.

    Read At: PubMed
  • Published on 5/11/2022

    Baidya A, Sangle S, Marbaniang I, Kulkarni V, Deshpande P, Nimkar S, Chavan A, Salvi S, Lokhande R, Kadam D, Gupta A, Mave V, Gupte AN. Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India. Open Forum Infect Dis. 2022 Jul; 9(7):ofac233. PMID: 35836747.

    Read At: PubMed

News & In the Media